TickerGuard
Buy Day today: Poor (57) Mixed market breadth · today: Nonfarm Payrolls (September)
PBYI

Puma Biotechnology, Inc.

Healthcare · Biotechnology

9.80$ -0.9% vs. previous close Closing price · As of: Oct 1, 2026

Statements

Balance Sheet

Puma Biotechnology, Inc. (PBYI) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Total Assets" came in at 193 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet PBYI
Line item Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26
204 231 214 205 221 213 196 195 203 216 193 193
125 156 143 138 157 148 133 137 144 163 142 145
82 85 77 67 67 69 63 55 54 30 36 37
85 96 107 97 97 101 93 96 94 98 102 94
29 48 25 28 55 32 25 26 34 54 26 34
5.7 7.1 7.1 9.0 2.7 8.7 8.8 8.6 9.5 5.5 8.7 13
63 61 58 56 54 51 49 46 44 41 39 37
165 177 163 156 150 121 99 90 88 86 64 54
67 99 98 104 110 96 87 79 83 81 60 50
27 39 50 50 51 51 51 38 36 24 11 0.5
5.1 6.9 9.0 14 7.5 5.5 6.0 5.4 6.4 5.1 8.2 3.1
77 66 55 44 33 22 11 11 – – – –
39 53 51 49 71 92 97 105 115 130 128 139
-1,357 -1,345 -1,350 -1,355 -1,334 -1,315 -1,312 -1,306 -1,297 -1,284 -1,288 -1,279
48 48 48 48 49 49 50 50 51 52 51 53

Data as of: October 1, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?